Asthma due to the complex salts of platinum--a cross-sectional survey of workers in a platinum refinery.
Anamnestic and immunological data of workers of a platinum refinery (group A: workers with work-related symptoms, n = 8; group B: workers with symptoms not clearly work-related, n = 9; group C: asymptomatic workers, n = 13) and controls (group D: atopics, n = 10; group E: non-atopics, n = 16) were compared. Exposure to platinum salt was higher in group A than in groups B or C. In group A, symptoms developed 4 months (median) after the onset of exposure. All subjects of group A and three workers of group B, but none of the workers of the other groups, showed a positive cutaneous reaction to (PtCl6)2-. Total serum IgE was higher in groups A and D than in groups B, C or E. (PtCl6)2(-)-specific IgE was higher in group A, but there was non-specific binding of (PtCl6)2- to IgE. Histamine release with (PtCl6)2- was found in all groups and was highest in atopic controls. Histamine release with (PtCl6)2- and histamine release with anti-IgE showed an excellent correlation, suggesting a similar release mechanism of (PtCl6)2- and anti-IgE. In skin-test positive subjects, high cutaneous (PtCl6)2(-)-sensitivity is linked to high histamine release with (PtCl6)2- or anti-IgE, supporting the concept of a role of cell surface IgE or IgE-Fc-receptor in the release process with platinum salts. However, high specificity of cutaneous reactions contrasts with low specificity of in-vitro tests with (PtCl6)2-. A different reaction of basophils and mast cells, when challenged with free platinum salts, is hypothesized. We conclude that neither histamine release from basophils with (PtCl6)2- nor RAST for the detection of (PtCl6)2- -specific IgE are helpful in the diagnosis of platinum salt allergy.
Merget
R
R
Hospital of the Johann Wolfgang Goethe-University, Department of Internal Medicine, Frankfurt am Main, FRG.
Schultze-Werninghaus
G
G
Muthorst
T
T
Friedrich
W
W
Meier-Sydow
J
J
D001249:Asthma / Q000139:chemically induced*; D003430:Cross-Sectional Studies; D004342:Drug Hypersensitivity / Q000209:etiology*; D006636:Histamine Release; D006801:Humans; D007073:Immunoglobulin E; D009784:Occupational Diseases / Q000139:chemically induced / Q000453:epidemiology*; D010984:Platinum / Q000009:adverse effects*; D012492:Salts; D012882:Skin Tests
D012492:Salts; D007073:Immunoglobulin E; D010984:Platinum